Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Jansen

Showing results (111-120 of 254) with videos related to

Pageof 26
Sort By:
Journal of Psychopharmacology (Oxford, England)|July 19, 2008
Risk of cerebrovascular events in elderly users of antipsychoticsB C Kleijer, R J van Marum, A C G Egberts, et al.
International Journal of Cancer|May 16, 1995
Alpha v-integrins in human melanoma: gain of alpha v beta 3 and loss of alpha v beta 5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude miceE H Danen, K F Jansen, A A Van Kraats, et al.
Cancer Research|September 15, 1996
Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumorsT Shimazui, J A Schalken, L A Giroldi, et al.
Pharmacy World & Science : PWS|December 16, 2004
Decrease of antiparkinsonian drugs before start of an antipsychotic in patients on levodopa treatment?David A M C van de Vijver, Raymund A C Roos, Paul A F Jansen, et al.
Journal of Medical Systems|January 22, 2016
Efficiency of Clinical Decision Support Systems Improves with ExperienceMichiel C Meulendijk, Marco R Spruit, Floor Willeboordse, et al.
European Journal of Clinical Pharmacology|May 16, 2002
Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatmentD A M C van de Vijver, R A C Roos, P A F Jansen, et al.
Cancer Research|July 26, 2000
Cadherin switching in human prostate cancer progressionK Tomita, A van Bokhoven, G J van Leenders, et al.
British Journal of Clinical Pharmacology|September 5, 2002
Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopaD A M C van de Vijver, R A C Roos, P A F Jansen, et al.
International Clinical Psychopharmacology|March 15, 2002
Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reportsI Schillevoort, E P van Puijenbroek, A de Boer, et al.
Acta Neurologica Scandinavica|March 21, 2002
Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa usersD A M C van de Vijver, R A C Roos, P A F Jansen, et al.
Pageof 26

Showing results (111-120 of 254) with videos related to

Sort By:
Pageof 26
Journal of Psychopharmacology (Oxford, England)|July 19, 2008
Risk of cerebrovascular events in elderly users of antipsychoticsB C Kleijer, R J van Marum, A C G Egberts, et al.
International Journal of Cancer|May 16, 1995
Alpha v-integrins in human melanoma: gain of alpha v beta 3 and loss of alpha v beta 5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude miceE H Danen, K F Jansen, A A Van Kraats, et al.
Cancer Research|September 15, 1996
Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumorsT Shimazui, J A Schalken, L A Giroldi, et al.
Pharmacy World & Science : PWS|December 16, 2004
Decrease of antiparkinsonian drugs before start of an antipsychotic in patients on levodopa treatment?David A M C van de Vijver, Raymund A C Roos, Paul A F Jansen, et al.
Journal of Medical Systems|January 22, 2016
Efficiency of Clinical Decision Support Systems Improves with ExperienceMichiel C Meulendijk, Marco R Spruit, Floor Willeboordse, et al.
European Journal of Clinical Pharmacology|May 16, 2002
Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatmentD A M C van de Vijver, R A C Roos, P A F Jansen, et al.
Cancer Research|July 26, 2000
Cadherin switching in human prostate cancer progressionK Tomita, A van Bokhoven, G J van Leenders, et al.
British Journal of Clinical Pharmacology|September 5, 2002
Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopaD A M C van de Vijver, R A C Roos, P A F Jansen, et al.
International Clinical Psychopharmacology|March 15, 2002
Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reportsI Schillevoort, E P van Puijenbroek, A de Boer, et al.
Acta Neurologica Scandinavica|March 21, 2002
Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa usersD A M C van de Vijver, R A C Roos, P A F Jansen, et al.
Pageof 26